Albemarle Corp.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US0126531013
USD
119.14
-7.35 (-5.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Albemarle Corp. stock-summary
stock-summary
Albemarle Corp.
Specialty Chemicals
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions. The bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Company serves various end markets, including petroleum refining, consumer electronics, energy storage, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services. As of December 31, 2016, the Company and its joint ventures operated 31 production and research and development (R&D) facilities, as well as a number of administrative and sales offices, around the world.
Company Coordinates stock-summary
Company Details
4250 Congress St Ste 900 , CHARLOTTE NC : 28209-4615
stock-summary
Tel: 1 980 29957001 980 2995641
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 147 Schemes (62.3%)

Foreign Institutions

Held by 421 Foreign Institutions (21.19%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Jerry Masters
Chairman of the Board, President, Chief Executive Officer
Mr. James O'Brien
Lead Independent Director
Ms. Mary Brlas
Independent Director
Ms. Glenda Minor
Independent Director
Mr. Diarmuid O'Connell
Independent Director
Mr. Dean Seavers
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,330 Million
(Quarterly Results - Jun 2025)
Net Profit:
35 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 9,650 Million (Small Cap)

stock-summary
P/E

7,040.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

148.24%

stock-summary
Debt Equity

0.17

stock-summary
Return on Equity

-0.92%

stock-summary
Price to Book

0.94